The functional activity of TMEM157 is intricately regulated by various chemical activators that target specific signaling pathways. For instance, activators that enhance adenylyl cyclase activity contribute to the elevation of intracellular cAMP levels, a second messenger known to be involved in a plethora of cellular functions. Such upregulation of cAMP can potentiate TMEM157 activity by promoting cAMP-dependent signaling processes, thereby indirectly impacting the modulation of this protein. Similarly, compounds capable of inhibiting phosphodiesterase activity complement this effect by preventing cAMP degradation, sustaining an environment conducive to the activation of TMEM157 within those pathways. Additionally, direct activators of protein kinase C play a crucial role by initiating PKC-dependent signaling cascades, which can upregulate the activity of TMEM157. Furthermore, the modulation of intracellular calcium concentrations through various means, including ionophores and channel activators, suggests a potential route for the indirect enhancement of TMEM157 if it is responsive to such ionic fluctuations.
Parallel to these mechanisms, other activators work by interfacing with distinct components of cellular signaling. Beta-adrenergic agonists, for example, elevate cAMP through receptor-mediated pathways, which might promote TMEM157 activity. Compounds that mimic cAMP's intracellular role or inhibit its degradation further underscore the importance of this signaling molecule in the regulation of TMEM157. Beyond the cAMP axis, modulation of protein tyrosine kinase activities suggests an alternative approach where inhibiting these kinases may shift the balance of cellular signaling in a way that indirectly activates TMEM157. Finally, alterations in ion homeostasis through the inhibition of ion pumps or through PI3K pathway manipulation provide additional layers of complexity and potential indirect activation of TMEM157, by modifying the cellular milieu in which this protein operates, all without invoking changes at the transcriptional or translational level, but rather through the nuanced interplay of signaling pathways and intracellular messengers.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Phosphodiesterase inhibitor which prevents cAMP degradation, potentially sustaining TMEM157 function in cAMP-mediated processes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Direct activator of protein kinase C (PKC) that could upregulate TMEM157 activity through PKC-dependent signaling cascades. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium concentration, which may indirectly enhance TMEM157 activity if it is calcium-responsive. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore that raises intracellular calcium levels, potentially stimulating TMEM157 if it operates within calcium-dependent pathways. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic agonist that elevates cAMP, possibly promoting TMEM157 activation through beta-adrenergic signaling pathways. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
L-type calcium channel activator which increases calcium influx, potentially affecting TMEM157 function in a calcium-dependent manner. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Membrane-permeable cAMP analog that could potentiate TMEM157 activity by mimicking cAMP's effect on its signaling pathways. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Selective phosphodiesterase 4 inhibitor, maintaining cAMP levels and potentially enhancing TMEM157 activity through cAMP-mediated signaling. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Protein tyrosine kinase inhibitor that may indirectly activate TMEM157 by modulating tyrosine kinase-dependent signaling pathways. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Inhibits Na+/K+-ATPase, potentially increasing intracellular sodium and calcium, which might indirectly stimulate TMEM157 if it is sensitive to ion changes. | ||||||